FCG Investment Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
2,688
+59
+2% +$60.3K 1.11% 21
2026
Q1
$2.42M Buy
+2,629
New +$2.67M 1.06% 20
2025
Q3
$2.02M Buy
2,645
+90
+4% +$67K 0.95% 26
2025
Q2
$1.99M Buy
2,555
+48
+2% +$37.3K 1.04% 24
2025
Q1
$2.07M Sell
2,507
-578
-19% -$481K 1.3% 22
2024
Q4
$2.38M Buy
3,085
+294
+11% +$243K 1.45% 18
2024
Q3
$2.47M Buy
2,791
+34
+1% +$30.6K 1.62% 16
2024
Q2
$2.5M Buy
2,757
+215
+8% +$172K 1.89% 12
2024
Q1
$1.98M Sell
2,542
-219
-8% -$156K 1.58% 15
2023
Q4
$1.61M Buy
+2,761
New +$1.61M 1.58% 17

Other funds holding LLY

FCG Investment Company's LLY Position: Q2 2026 in Review

FCG Investment Company increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $60.3K and bringing the position to 2,688 shares worth $3.22M. The position accounts for 1.11% of the portfolio, ranked #21.

FCG Investment Company first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FCG Investment Company held 2,688 shares of Eli Lilly worth $3.22M as of Q2 2026.
  • FCG Investment Company bought 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
  • Eli Lilly made up 1.11% of FCG Investment Company's portfolio in Q2 2026, its #21 holding.
  • FCG Investment Company first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.